Method of detecting cancer
OwnerJun Nakayama, Satoshi Ishizoneinventors
Life of this patent
Estimating the term…
Abstract
Cancer is detected by measuring the expression level of α 1,4-N-acetyl-D-glucosamine transferase gene in a body fluid collected from a living body to correlate the measurement value with presence or absence, development, degree of progress, or prognosis of cancer, wherein expression level of said gene is measured by detecting an arbitrary region consisting of continuous nucleotides having a length of 70 to 139 bp in the nucleotide sequence of SEQ ID NO:1.
Claims9
A method of detecting cancer comprising measuring the expression level of α-1,4-N-acetyl-D-glucosamine transferase gene in a body fluid collected from a living body to correlate the measurement value with the presence or absence, development, degree of progress, or prognosis of cancer, wherein expression level of said gene is measured by detecting an arbitrary region consisting of continuous nucleotides having a length of 70 to 139 bp in the nucleotide sequence of SEQ ID NO:
- 1.
A method of determining a degree of progress of pancreatic cancer comprising measuring the expression level of α-1,4-N-acetyl-D-glucosamine transferase gene in a body fluid collected from a living body to correlate the measurement value with the degree of progress of the pancreatic cancer, wherein the expression level of said gene is measured by detecting an arbitrary region consisting of continuous nucleotide sequence having a length of 70 to 139 bp in the nucleotide sequence of SEQ ID NO:
- 1.
A kit for detecting cancer, comprising primers for amplifying an arbitrary region consisting of continuous nucleotide sequence having a length of 70 to 139 bp in the nucleotide sequence of SEQ ID NO:
- 1.
Dependencies are inferred from the claim text.